Drupal.behaviors.print = function(context) {window.print();window.close();}>
Illumina Aims for Single-Molecule Sequencing, Launches New Business Unit for the Clinical Market
January 10, 2012
Illumina Aims for Single-Molecule Sequencing, Launches New Business Unit for the Clinical Market
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
NIPT and Cancer Drive Illumina's Clinical Business in Q1 as it Looks to Launch Fetal Aneuploidy IVD
April 24, 2013 / Clinical Sequencing News
Resurgence in HiSeq Sales Helps Drive Illumina Revenue Growth in Q1 2013
April 23, 2013 / In Sequence
Illumina Focuses on Reproductive Health; May Modify MiSeq/HiSeq for Different Clinical Needs
January 30, 2013 / Clinical Sequencing News
MiSeq, Consumables, Services Drive Illumina's Q4 Revenues as it Begins Work on Nanopore Sequencing
January 29, 2013 / In Sequence
MiSeq Customers, WGS Service, and T21 Test Developers Drive Illumina's Clinical Business
October 24, 2012 / Clinical Sequencing News